Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
David Henry MacK | President and CEO | 2025-01-03 | 17,709 | $0.53 | $9.39kBuy |
David Henry MacK | President and CEO | 2024-12-03 | 91,750 | $0.53 | $48.63kBuy |
Michael Carulli | Chief Financial Officer | 2024-09-11 | 2,891 | $1.50 | $4.35kSell |
Deepika Jalota | Chief Development Officer | 2024-09-11 | 7,218 | $1.50 | $10.86kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Advisors LLC | 12.69% | 6,589,330 | $8.17M | Insider |
Orbimed Advisors LLC | 12.47% | 6,475,291 | $8.03M | Institution |
Arnold L. Oronsky | 12.46% | 6,469,911 | $8.02M | Insider |
Interwest Partners X LP | 8.67% | 4,502,480 | $5.58M | Insider |
Sio Capital Management LLC | 6.88% | 3,572,167 | $4.43M | Institution |
Arrowmark Colorado Holdings LLC | 6.76% | 3,508,451 | $4.35M | Institution |
Bml Capital Management LLC | 6.68% | 3,466,684 | $4.30M | Institution |
Euclidean Capital LLC | 5.06% | 2,627,643 | $3.26M | Institution |
V. Oncology Scs Sicavsif Nextech | 4.87% | 2,528,290 | $3.14M | Insider |
Alkeon Capital Management LLC | 4.51% | 2,343,731 | $2.91M | Institution |